Exp Clin Endocrinol Diabetes 2007; 115(3): 192-197
DOI: 10.1055/s-2007-970426
Case Report

© J. A. Barth Verlag in Georg Thieme Verlag KG · Stuttgart · New York

Glucose Metabolism, Insulin Secretion and Insulin Sensitivity in Juvenile Hemochromatosis. A Case Report and Review of the Literature.

N. Angelopoulos 1 , G. Papanikolaou 3 , M. Noutsou 2 , G. Rombopoulos 1 , A. Goula 1 , G. Tolis 1
  • 1Endocrine Department, “Hippokrateion” Hospital of Athens, Athens, Greece
  • 2Diabetes Center, 2nd Medical Department “Hippokrateion” Hospital of Athens, Athens, Greece
  • 3First Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Further Information

Publication History

received 20. 3. 2006 first decision 30. 10. 2006

accepted 30. 10. 2006

Publication Date:
11 April 2007 (online)

Abstract

Among specific diabetes subtypes secondary to pancreatopathies, hereditary hemochromatosis is an inherited disorder of iron metabolism resulting in excessive iron overload and tissue damage in various organs. We here report the case of a man with the young-onset form of the disease and describe his glycaemic status before and during venesection therapy. A 25-year old man visited our clinic in Athens, Greece, with hypogonadotropic hypogonadism due to hereditary hemochromatosis. Genetic analysis revealed that he was suffering from the juvenile aggressive form and treatment was initiated with frequent phlebotomies in conjunction with androgen substitution. Within 18 months of therapy ferritin level was normalized and hypogonadism was fully restored. Despite severe iron overload, glucose tolerance remained normal during the vari-ous stages of the disease, although alterations in both insulin secretion and sensitivity were detected. Present data indicate that in juvenile hemochromatosis, the efficacy of the chelation therapy and probably the chronic interval required to restore normal iron concentration both play important roles in the formation of glucose metabolism characteristics.

References

  • 1 Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene.  Am J Med. 1991;  90 445-449
  • 2 Angelopoulos NG, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D, Tolis G. Hypoparathyroidism in transfusion dependent patients with β-Thalassemia.  J Bone Miner Metab. 2006;  24 138-145
  • 3 Angelopoulos N, Zervas A, Livadas S, Adamopoulos I, Giannopoulos D, Goula A, Tolis G. Reduced insulin secretion in normoglycemic patients with β-thalassemia major.  Diabetic Medicine. , In press
  • 4 Angelopoulos NG, Katounda E, Rombopoulos G, Goula A, Kaltzidou V, Kaltsas D, Ioannis P, Tolis G. Evaluation of bone mineral density of the lumbar spine in patients with b-thalassemia major with Dual-Energy X-Ray Absorptiometry and Quantitative Computed Tomography. A comparison study.  J Pediatr Hematol Oncol. 2006;  28 73-78
  • 5 Bacon BR. Diagnosis and management of hemochromatosis.  Gastroenterology. 1997;  113 995-999
  • 6 Bierens de Haan B, Scherrer JR, Stauffacher W, Pometta D. Iron excess, early glucose intolerance and impaired insulin secretion in idiopathic hemochromatosis.  Eur J Clin Invest. 1973;  3 179-187
  • 7 Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassemia major with secondary haemochromatosis: assessment by oral glucose tolerance test.  Eur J Pediatr. 2003;  162 139-146
  • 8 Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, O'Rahilly S, Shore S, Tom BD, Alexander GJ. Further evidence for an association between non-insulindependent diabetes mellitus and chronic hepatitis C virus infection.  Hepatology. 1999;  30 1059-1063
  • 9 Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis.  Endocrinology. 2004;  145 5305-5312
  • 10 De Gobbi M, Roetto A, Piperno A, Mariani R, Alberti F, Papanikolaou G, Politou M, Lockitch G, Girelli D, Fargion S, Cox TM, Gasparini P, Cazzola M, Camaschella C. Natural history of juvenile hemochromatosis.  Br J Haematol. 2002;  117 973-979
  • 11 Dymock IW, Williams R. Hemochromatosis and diabetes.  Postgrad Med J. 1971;  Suppl 79-83
  • 12 Dymock IW, Cassar J, Pyke DA, Oakley WG, William R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of hemochromatosis.  Am J Med. 1972;  52 203-210
  • 13 Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo Jr R, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis.  Nat Genet. 1996;  13 399-408
  • 14 Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.  Am J Epidemiol. 2000;  151 190-198
  • 15 Hramiak IM, Finegood DT, Adams PC. Factors affecting glucose tolerance in hereditary hemochromatosis.  Clin Invest Med. 1997;  20 110-118
  • 16 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
  • 17 Minami A, Iseki M, Kishi K, Wang M, Ogura M, Furukawa N, Hayashi S, Yamada M, Obata T, Takeshita Y, Nakaya Y, Bando Y, Izumi K, Moodie SA, Kajiura F, Matsumoto M, Takatsu K, Takaki S, Ebina Y. Increased insulin sensitivity and hypoinsulinemia in APS knockout mice.  Diabetes. 2003;  52 2657-2665
  • 18 McClain DA, Abraham D, Rogers J, Brady R, Gault P, Ajioka R, Kushner JP. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis.  Diabetologia. 2006;  49 1661-1669
  • 19 Nelson RL, Baldus WP, Rubenstein AH, Go VL, Service FJ. Pancreatic alpha-cell function in diabetic hemochromatotic subjects.  J Clin Endocrinol Metab. 1979;  49 412-416
  • 20 Niederau C, Rischer R, Sonnenberg A, Wolfgang S, Trampisch H, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.  N Engl J Med. 1985;  313 1256-1262
  • 21 Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis.  Gastroenterology. 1996;  110 1107-1119
  • 22 Oberley L. Free radicals and diabetes.  Free Radic Biol Med. 1988;  5 113-124
  • 23 Olefsky JM. Insulin resistance and the pathogenesis of non-insulin dependent diabetes mellitus: cellular and molecular mechanisms.  Adv Exp Med Biol. 1993;  334 129-150
  • 24 Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP. Mutations in HFE2 cause iron overload in chromosome 1qlinked juvenile hemochromatosis.  Nat Genet. 2004;  36 77-82
  • 25 Rahier J, Loozen S, Goebbels RM, Abraham M. The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study.  Diabetologia. 1987;  30 5-12
  • 26 Rizza RA, Mandarino LJ, Genest J, Baker BA, Gerich JE. Production of insulin resistance by hyperinsulinaemia in man.  Diabetologia. 1985;  28 70-75
  • 27 Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.  Nat Genet. 2003;  33 21-22
  • 28 Saudek CD, Hemm RM, Peterson CM. Abnormal glucose tolerance in b-thalassaemia.  Metabolism. 1977;  26 43-52
  • 29 Salonen JT, Nyyssonen K, Tuomainen TP, Maenpaa PH, Korpela H, Kaplan GA, Lynch J, Helmrich SP, Salonen R. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four-year follow-up study in men.  BMJ. 1995;  311 1124-1127
  • 30 Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM, Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: case-control study.  BMJ. 1998;  317 727
  • 31 Seltzer HS, Allen W, Herron AL, Brennan MT. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.  J Clin Invest. 1967;  46 323-334
  • 32 Stremmel W, Niederau C, Berger M, Kley H-K, Kruskemper H-L, Strohmeyer G. Abnormalities in estrogen, androgen, and insulin metabolism in idiopathic hemochromatosis.  Ann N Y Acad Sci. 1988;  526 209-223
  • 33 Tai M. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves.  Diabetes Care. 1994;  17 152-154
  • 34 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.  Diabetes Care. 2003;  26 S5-20
  • 35 Volpi E, Lieberman SA, Ferrer DM, Gilkison CR, Rasmussen BB, Nagamani M, Urban RJ. The relationships between testosterone, body composition, and insulin resistance: a lesson from a case of extreme hyperandrogenism.  Diabetes Care. 2005;  28 429-432

Correspondence

N. Angelopoulos

Division of Endocrinology and Metabolism

“Hippokrateion” Hospital of Athens

Vassilisis Sofias Avenue 108

115 27 Athens

Greece

Phone: +30/210/866 81 81

Fax: +30/210/778 68 89

Email: drangelnick@hotmail.com

    >